4-nitroquinoline-1-oxide has been researched along with taiwanin c in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bau, DT; Chen, MC; Chen, YC; Hsu, HH; Huang, CY; Kuo, YH; Lin, KH; Shibu, MA; Tu, CC; Viswanadha, VP | 1 |
Bau, DT; Chen, MC; Day, CH; Ho, CC; Hsieh, CH; Hsu, HH; Huang, CY; Lin, YM; Shibu, MA; Wang, SH | 1 |
Ban, B; Chen, YH; Chou, YC; Day, CH; Fang, HY; Huang, CY; Lin, YM; Shen, CY; Shibu, MA; Tsai, CY | 1 |
3 other study(ies) available for 4-nitroquinoline-1-oxide and taiwanin c
Article | Year |
---|---|
Taiwanin C selectively inhibits arecoline and 4-NQO-induced oral cancer cell proliferation via ERK1/2 inactivation.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents, Phytogenic; Arecoline; Cell Cycle Proteins; Cell Proliferation; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Lactones; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mouth Neoplasms | 2017 |
Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
Topics: 4-Nitroquinoline-1-oxide; Animals; Arecoline; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Lactones; Lignans; Mice; Mouth Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Taiwanin C elicits apoptosis in arecoline and 4-nitroquinoline-1-oxide-induced oral squamous cell carcinoma cells and hinders proliferation via epidermal growth factor receptor/PI3K suppression.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Arecoline; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Lactones; Lignans; Male; Mice, Inbred C57BL; Mouth Neoplasms; Phosphoinositide-3 Kinase Inhibitors | 2019 |